| Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial TU Marron, MI Fiel, P Hamon, N Fiaschi, E Kim, SC Ward, Z Zhao, J Kim, ... The Lancet Gastroenterology & Hepatology 7 (3), 219-229, 2022 | 102 | 2022 |
| Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma A Magen, P Hamon, N Fiaschi, BY Soong, MD Park, R Mattiuz, E Humblin, ... Nature medicine 29 (6), 1389-1399, 2023 | 73* | 2023 |
| TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer MD Park, I Reyes-Torres, J LeBerichel, P Hamon, NM LaMarche, ... Nature immunology 24 (5), 792-801, 2023 | 37 | 2023 |
| 18F-6-Fluoro-l-Dopa PET/CT imaging of congenital hyperinsulinism JC Davis, SM Hamel, SA Becker, H Zhuang Journal of Nuclear Medicine 62 (Supplement 2), 51S-56S, 2021 | 6 | 2021 |
| Characterization of molecular and spatial diversity of macrophages in hepatocellular carcinoma P Hamon, A Magen, M Cohen, A Tabachnikova, C Chang, M Buckup, ... Cancer Research 81 (13_Supplement), 64-64, 2021 | 1 | 2021 |
| Abstract LB079: An end-to-end Visium spatial transcriptomics computational pipeline for generating low-code interactive reports of spatial insights S Hamel, E Cheung, Y Qu, M Loviska, A Mayer, L Zhang, T Lu, ... Cancer Research 83 (8_Supplement), LB079-LB079, 2023 | | 2023 |
| Single cell spatial phenotyping of bladder tumors with a novel mechanism of NKG2A and HLA-E mediated resistance to BCG immunotherapy D Klymyshyn, N Jhaveri, N Nelson, M Prater, Z Wu, S Hamel, MD Galsky, ... Cancer Research 83 (7_Supplement), 5648-5648, 2023 | | 2023 |
| Immune profiling of immunotherapy and adjuvant chemotherapy pretreatment NSCLC tissues by CODEX J Monkman, A Moradi, C O'Leary, Z Wu, S Hamel, D Mason, F Schneider, ... Cancer Research 83 (7_Supplement), 4627-4627, 2023 | | 2023 |
Miriam MeradMount Sinai school of medicineVerified email at mssm.edu
